The Generalized Anxiety Disorder 7-Item Scale in Adolescents with Generalized Anxiety Disorder: Signal Detection and Validation

Abstract

Background

In pediatric patients with anxiety disorders, existing symptom inventories are either not freely available or require extensive time and effort to administer. We sought to evaluate a brief self-report scale— the Generalized Anxiety Disorder 7-item scale (GAD-7)—in adolescents with generalized anxiety disorder (GAD).

Methods

The Pediatric Anxiety Rating Scale (PARS) and the GAD-7 were administered to youth with GAD (confirmed by structured interview). Relationships between the measures were assessed, and sensitivity and specificity was determined with regard to a global symptom severity measure (Clinical Global Impression-Severity).

Results

In adolescents with GAD (N = 40; mean age, 14.8 ± 2.8), PARS and GAD-7 scores strongly correlated (R = 0.65, P < .001) and a main effect for symptom severity was observed (P < .001). GAD-7 scores ≥11 and ≥17 represented the optimum specificity and sensitivity for detecting moderate and severe anxiety, respectively.

Conclusions

The PARS and GAD-7 similarly reflect symptom severity. The GAD-7 is associated with acceptable specificity and sensitivity for detecting clinically significant anxiety symptoms. GAD-7 scores may be used to assess anxiety symptoms and to differentiate between mild and moderate GAD in adolescents, and may be more efficient than the PARS.

Get full access to this article

View all access options for this article.

References

Kessler

Avenevoli

Costello

. Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69:381–389.

Chavira

Stein

Bailey

. Child anxiety in primary care: prevalent but untreated. Depress Anxiety. 2004;20:155–164.

Spitzer

Kroenke

Williams

. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–1097.

Hamilton

The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55.

Norman

Campbell-Sills

Hitchcock

. Psychometrics of a brief measure of anxiety to detect severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS). J Psychiatr Res. 2011;45:262–268.

Stein

Sareen

Clinical practice. Generalized anxiety disorder. N Engl J Med. 2015;373:2059–2068.

Birmaher

Brent

Chiappetta

. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999;38:1230–1236.

March

Parker

Sullivan

. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:554–565.

The Research Units on Pediatric Psychopharmacology Anxiety Study Group. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002;41: 1061–1069.

10.

Winters

Collett

Myers

. Ten-year review of rating scales, VII: scales assessing functional impairment. J Am Acad Child Adolesc Psychiatry. 2005;44:309-338-342; discussion 339–342.

11.

Crawley

Caporino

Birmaher

. Somatic complaints in anxious youth. Child Psychiatry Hum Dev. 2014;45:398–407.

12.

Kendall

Chansky

. Considering cognition in anxiety-disordered children. J Anxiety Disord. 1991;5:167–185.

13.

Walkup

Albano

Piacentini

. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359: 2753–2766.

14.

Strawn JR Prakash

Zhang

. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:283–293.

15.

Birmaher

Axelson

Monk

. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2003;42:415–423.

16.

Walkup

Labellarte

Riddle

. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl J Med. 2001;344:1279–1285.

17.

Caporino

Brodman

Kendall

. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. J Am Acad Child Adolesc Psychiatry. 2013;52:57–67.

18.

Birmaher

Khetarpal

Brent

. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36:545–553.

19.

Garía-Campayo

, Zamorano

, Ruiz

, . Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes. 2010;8:8.

20.

Guy

Clinical Global Impressions. In: ECDEU assessment manual. Rockville, MD: U.S. Department of Health, Education, and Welfare; 1976:217–222.

21.

Silverman

Saavedra

Pina

. Test-retest reliability of anxiety symptoms and diagnoses with the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions. J Am Acad Child Adolesc Psychiatry. 2001;40:937–944.

22.

Duke

Litt

Gross

. Adolescents’ selfassessment of sexual maturation. Pediatrics. 1980;66: 918–920.

23.

Patel

DelBello

Kowatch

. Preliminary study of relationships among measures of depressive symptoms in adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2006;16:327–335.

24.

Swets

. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–1293.

25.

Swets

Dawes

Monahan

Psychological science can improve diagnostic decisions. Psychol Sci Public Interest. 2000;1:1–26.

26.

Lopez-Raton

Rodriguez-Álvarez

Cadarso-Suarez

. Optimal Cutpoints: an R package for selecting optimal cutpoints in diagnostic tests. J Stat Softw. 2014;61:1–36.

27.

Gallop

Crits-Christoph

Muenz

. Determination and interpretation of the optimal operating point for ROC curves derived through generalized linear models. Underst Stat. 2003;2:219–242.

28.

Settipani

Kendall

. The effect of child distress on accommodation of anxiety: relations with maternal beliefs, empathy, and anxiety. J Clin Child Adolesc Psychol. 2015;16:1–14.

29.

Mancini

Wade

Perugi

. Impact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressants. J Psychiatr Res. 2014;51:21–29.

30.

Dobson

Strawn JR . Placebo response in pediatric anxiety disorders: implications for clinicaltrials design and interpretation. J Child Adolesc Psychopharmocology. 2016;26:686–693.

31.

Byrom

Mundt

. The value of computer-administered self-report data in central nervous system clinical trials. Curr Opin Drug Discov Devel. 2005;8:374–383.

32.

Strawn JR Welge

Wehry

. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. Depress Anxiety. 2015;32:149–157.

33.

Connolly

Bernstein

; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:267–283.

34.

Hannan

Lambert

Harmon

. A lab test and algorithms for identifying clients at risk for treatment failure. J Clin Psychol. 2005;61: 155–163.